CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Finally, to determine the clinical importance of our findings, we analyzed FAM167A levels in CD34+ stem/progenitor cells isolated from CML patients (Additional file 1: Table S1) by qRT-PCR.